{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:46:39Z","timestamp":1790653599620,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00277-016-2779-7","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:04:56Z","timestamp":1470873896000},"page":"1853-1857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of neutrophil\u2013lymphocyte ratio in patients with early-stage mycosis fungoides"],"prefix":"10.1007","volume":"95","author":[{"given":"Rafet","family":"Eren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihan","family":"Nizam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Hilmi","family":"Do\u011fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Mercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131 Vefa Turgut","family":"Erdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Suyan\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u20133785","journal-title":"Blood"},{"key":"2779_CR2","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 113:5064\u20135073","journal-title":"Blood"},{"key":"2779_CR3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","volume":"42","author":"F Trautinger","year":"2006","unstructured":"Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L, D\u2019Incan M, Ranki A, Pimpinelli N, Ortiz-Romero P, Dummer R, Estrach T, Whittaker S (2006) EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome. Eur J Cancer 42:1014\u20131030","journal-title":"Eur J Cancer"},{"key":"2779_CR4","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2015-12-611830","volume":"127","author":"S Whittaker","year":"2016","unstructured":"Whittaker S, Hoppe R, Prince HM (2016) How I treat mycosis fungoides and Sezary syndrome. Blood 127:3142\u20133153","journal-title":"Blood"},{"key":"2779_CR5","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ajh.23756","volume":"89","author":"RA Wilcox","year":"2014","unstructured":"Wilcox RA (2014) Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 89:837\u2013851. doi: 10.1002\/ajh.23756","journal-title":"Am J Hematol"},{"key":"2779_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erc.12.159","volume":"11","author":"T Bhat","year":"2013","unstructured":"Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11:55\u201359. doi: 10.1586\/erc.12.159","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2779_CR7","first-page":"14779","volume":"8","author":"SQ Gao","year":"2015","unstructured":"Gao SQ, Huang LD, Dai RJ, Chen DD, Hu WJ, Shan YF (2015) Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn\u2019s disease severity. Int J Clin Exp Pathol 8:14779\u201314785","journal-title":"Int J Clin Exp Pathol"},{"key":"2779_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5455\/msm.2014.231-233","volume":"26","author":"A Ataseven","year":"2014","unstructured":"Ataseven A, Bilgin AU, Kurtipek GS (2014) The importance of neutrophil lymphocyte ratio in patients with psoriasis. Mater Sociomed 26:231\u2013233. doi: 10.5455\/msm.2014.231-233","journal-title":"Mater Sociomed"},{"key":"2779_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.kjms.2015.10.010","volume":"31","author":"S Alan","year":"2015","unstructured":"Alan S, Tuna S, T\u00fcrko\u011flu EB (2015) The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Beh\u00e7et\u2019s syndrome. Kaohsiung J Med Sci 31:626\u2013631. doi: 10.1016\/j.kjms.2015.10.010","journal-title":"Kaohsiung J Med Sci"},{"key":"2779_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221\u2013233","journal-title":"Mol Cancer Res"},{"key":"2779_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-7682-5-2","volume":"5","author":"F Imtiaz","year":"2012","unstructured":"Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S (2012) Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 5:2. doi: 10.1186\/1755-7682-5-2","journal-title":"Int Arch Med"},{"key":"2779_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1346-8138.13061","volume":"43","author":"DS Kim","year":"2016","unstructured":"Kim DS, Shin D, Lee MS, Kim HJ, Kim do Y, Kim SM, Lee MG (2016) Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol 43:305\u2013310. doi: 10.1111\/1346-8138.13061","journal-title":"J Dermatol"},{"key":"2779_CR13","first-page":"65","volume":"23","author":"EN Rifaioglu","year":"2014","unstructured":"Rifaioglu EN, B\u00fclb\u00fcl \u015een B, Ekiz \u00d6, Cigdem Dogramaci A (2014) Neutrophil to lymphocyte ratio in Beh\u00e7et\u2019s disease as a marker of disease activity. Acta Dermatovenerol Alp Pannonica Adriat 23:65\u201367","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"2779_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.clinre.2012.06.004","volume":"36","author":"S Torun","year":"2012","unstructured":"Torun S, Tunc BD, Suvak B, Yildiz H, Tas A, Sayilir A, Ozderin YO, Beyazit Y, Kayacetin E (2012) Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol 36:491\u2013497. doi: 10.1016\/j.clinre.2012.06.004","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2779_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.kjms.2015.10.001","volume":"31","author":"AK Demir","year":"2015","unstructured":"Demir AK, Demirtas A, Kaya SU, Tastan I, Butun I, Sagcan M, Sahin S, Tasliyurt T, Yilmaz A (2015) The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis. Kaohsiung J Med Sci 31:585\u2013590. doi: 10.1016\/j.kjms.2015.10.001","journal-title":"Kaohsiung J Med Sci"},{"key":"2779_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jcla.21564","volume":"27","author":"M Celikbilek","year":"2013","unstructured":"Celikbilek M, Dogan S, Ozbak\u0131r O, Zarars\u0131z G, K\u00fcc\u00fck H, G\u00fcrsoy S, Yurci A, G\u00fcven K, Y\u00fccesoy M (2013) Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 27:72\u201376. doi: 10.1002\/jcla.21564","journal-title":"J Clin Lab Anal"},{"key":"2779_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88:218\u2013230. doi: 10.1016\/j.critrevonc.2013.03.010","journal-title":"Crit Rev Oncol Hematol"},{"key":"2779_CR18","doi-asserted-by":"publisher","unstructured":"18-Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106:dju124. doi: 10.1093\/jnci\/dju124 .","DOI":"10.1093\/jnci\/dju124"},{"key":"2779_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00277-013-1978-8","volume":"93","author":"E Kelkitli","year":"2014","unstructured":"Kelkitli E, Atay H, Cilingir F, G\u00fcler N, Terzi Y, Ozatl\u0131 D, Turgut M (2014) Predicting survival for multiple myeloma patients using baseline neutrophil\/lymphocyte ratio. Ann Hematol 93:841\u2013846. doi: 10.1007\/s00277-013-1978-8","journal-title":"Ann Hematol"},{"key":"2779_CR20","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3109\/10428194.2014.982642","volume":"56","author":"B Keam","year":"2015","unstructured":"Keam B, Ha H, Kim TM, Jeon YK, Lee SH, Kim DW, Kim CW, Heo DS (2015) Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma 56:2032\u20132038. doi: 10.3109\/10428194.2014.982642","journal-title":"Leuk Lymphoma"},{"key":"2779_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ajh.21849","volume":"85","author":"LF Porrata","year":"2010","unstructured":"Porrata LF, Ristow K, Habermann T, Inwards DJ, Micallef IN, Markovic SN (2010) Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil\/lymphocyte ratio. Am J Hematol 85:896\u2013899. doi: 10.1002\/ajh.21849","journal-title":"Am J Hematol"},{"key":"2779_CR22","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1309\/AJCPO46GFKGNXCBR","volume":"138","author":"YW Koh","year":"2012","unstructured":"Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Kim JE, Kim CW, Huh J (2012) Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma. Am J Clin Pathol 138:846\u2013854. doi: 10.1309\/AJCPO46GFKGNXCBR","journal-title":"Am J Clin Pathol"},{"key":"2779_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/10428194.2015.1045897","volume":"57","author":"BE Beltran","year":"2016","unstructured":"Beltran BE, Aguilar C, Qui\u00f1ones P, Morales D, Chavez JC, Sotomayor EM, Castillo JJ (2016) The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma 57:58\u201362. doi: 10.3109\/10428194.2015.1045897","journal-title":"Leuk Lymphoma"},{"key":"2779_CR24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S, ISCL\/EORTC (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713\u20131722","journal-title":"Blood"},{"key":"2779_CR25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","volume":"40","author":"HS Zackheim","year":"1999","unstructured":"Zackheim HS, Amin S, Kashani-Sabet M, McMillan A (1999) Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients. J Am Acad Dermatol 40:418\u2013425","journal-title":"J Am Acad Dermatol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2779-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2779-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:27:01Z","timestamp":1498336021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2779-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2779-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]}}}